Trial ID or NCT#

NCT00958841

Status

NOT RECRUITING

Purpose

This study will assess the effectiveness and safety of pasireotide long-acting release in patients who have rare tumors of neuroendocrine origin.

Official Title

An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rare Tumors of Neuroendocrine Origin

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Francois Haddad
Cardiologist
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Y. Joyce Liao, MD, PhD
Neuro-ophthalmology specialist
Associate Professor of Ophthalmology and of Neurology at the Stanford University Medical Center
Pamela L. Kunz
Medical oncologist, Gastrointestinal specialist
Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Cancer Clinical Trials Office
(650) 498-7061